What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Equine Strangles (Streptococcus equi): Outbreak Management and Molecular Epidemiology

Introduction

Equine strangles is a highly contagious bacterial disease of equids caused by Streptococcus equi subspecies equi (S. equi). The disease is characterized by acute febrile illness, purulent lymphadenopathy of the head and neck, and guttural pouch empyema. Outbreaks cause significant economic losses through morbidity, mortality, treatment costs, and movement restrictions. Effective outbreak management requires rapid diagnosis, identification of carrier animals, molecular typing for epidemiological tracing, and strict biosecurity protocols. This article provides a detailed review of the molecular epidemiology of S. equi, focusing on SeM typing and quantitative PCR (qPCR) for carrier detection, and outlines evidence-based outbreak management strategies including guttural pouch sampling, vaccination, and decontamination.

Etiology and Pathogenesis

Streptococcus equi subsp. equi is a Lancefield group C beta-hemolytic streptococcus. It is a host-adapted pathogen of horses, donkeys, and mules, with no significant zoonotic potential. The bacterium expresses a hyaluronic acid capsule that inhibits phagocytosis, and a variety of surface proteins including the antiphagocytic M-like protein SeM (S. equi M-protein) [1, 2]. SeM is a critical virulence factor and the primary target for serological typing and molecular epidemiology.

Transmission occurs via direct contact with purulent discharges from abscesses or nasal secretions, or indirectly through contaminated fomites, water troughs, and grooming equipment [3]. The incubation period ranges from 3 to 14 days. Following inhalation or ingestion, S. equi colonizes the nasopharynx and tonsillar tissues, then invades the regional lymph nodes (submandibular and retropharyngeal), causing suppurative lymphadenitis [4]. Abscess formation is a hallmark of the disease. In some cases, infection spreads to the guttural pouches, leading to empyema and the development of persistent carrier states [5].

Clinical Signs and Carrier State

Acute strangles presents with fever (39.5-41.0 degrees C), depression, anorexia, nasal discharge (initially serous, later mucopurulent), and painful swelling of the submandibular and retropharyngeal lymph nodes [6]. Abscesses may rupture externally or internally, with potential complications including guttural pouch empyema, chondroids, bastard strangles (metastatic abscessation), purpura hemorrhagica (immune-mediated vasculitis), and agalactia in mares [7, 8].

The carrier state is a critical epidemiological feature. Approximately 10-15% of recovered horses continue to shed S. equi intermittently from the guttural pouches for months to years [9]. These carriers are often clinically normal but serve as a reservoir for new outbreaks. Detection of carriers requires sampling of the guttural pouches via endoscopy or lavage, followed by culture or qPCR [10].

Molecular Epidemiology

SeM Typing

SeM is a highly variable surface protein encoded by the seM gene. Sequence analysis of the seM gene is the gold standard for molecular typing of S. equi isolates [11]. The gene contains a hypervariable region encoding the N-terminal portion of the protein, which is under diversifying selection due to host immune pressure [12]. SeM typing differentiates strains into allelic types (SeM types) that are used for outbreak tracing and global epidemiological studies.

The SeM typing protocol involves PCR amplification of the seM gene followed by Sanger sequencing. Sequences are compared to a curated database (e.g., the S. equi SeM database maintained by the Animal Health Trust) to assign an allelic type [13]. More than 200 SeM types have been described worldwide [14]. SeM typing has revealed that certain types are geographically restricted, while others are globally distributed, indicating long-distance spread via horse movement [15].

Quantitative PCR for Carrier Detection

Real-time quantitative PCR (qPCR) targeting the seM gene or the superantigen gene seeH is highly sensitive and specific for detecting S. equi DNA in clinical samples [16, 17]. qPCR is superior to culture for detecting low-level shedding in carriers, as it can detect as few as 10-100 colony-forming units per swab [18]. The assay is typically performed on nasopharyngeal swabs, guttural pouch lavage fluid, or abscess exudate.

A positive qPCR result from a guttural pouch sample in a clinically normal horse is strongly indicative of a carrier state. However, qPCR cannot distinguish viable from non-viable organisms; therefore, positive results should be interpreted in conjunction with clinical history and follow-up culture if needed [19]. Multiplex qPCR panels that simultaneously detect S. equi and other respiratory pathogens (e.g., equine herpesvirus-1, equine influenza virus) are available for differential diagnosis [20].

Genomic Epidemiology

Whole-genome sequencing (WGS) has been applied to S. equi to resolve transmission networks and identify antimicrobial resistance determinants [21, 22]. Core genome multilocus sequence typing (cgMLST) provides higher discriminatory power than SeM typing alone and is increasingly used for outbreak investigations [23]. WGS has also revealed the presence of prophage-encoded superantigens (e.g., SeeH, SeeI, SeeL) that contribute to the severity of disease [24].

Outbreak Management

Diagnostic Confirmation

Rapid confirmation of strangles is essential for implementing control measures. Diagnostic options include:

Bacterial culture: Selective media (e.g., blood agar with colistin and nalidixic acid) incubated at 37 degrees C for 24-48 hours. Colonies are beta-hemolytic, catalase-negative, and Lancefield group C positive [25].
qPCR: Preferred for rapid detection (within 2-4 hours). High sensitivity, especially in carrier samples [26].
Serology: Indirect ELISA targeting SeM or other surface proteins can detect antibodies indicative of recent infection or vaccination. Serology is useful for herd screening but cannot distinguish infected from vaccinated animals (DIVA) unless a specific marker is used [27, 28].

Guttural Pouch Sampling

Endoscopic examination of the guttural pouches is the definitive method for identifying carriers. A sterile guarded swab or lavage catheter is used to collect material from the pouch floor. The sample is submitted for qPCR and culture [29]. In field settings, a blind guttural pouch lavage technique using a flexible tube inserted via the nasal passage can be performed without endoscopy, though it has lower sensitivity [30].

Biosecurity and Quarantine

Outbreak control relies on strict biosecurity:

Isolation: All horses with clinical signs or positive test results should be isolated immediately. Isolation facilities should be physically separate from the main herd, with dedicated equipment and personnel [31].
Movement restrictions: No horses should enter or leave the premises until the outbreak is resolved. Quarantine duration is typically 4-6 weeks after the last clinical case resolves, with negative test results from all exposed horses [32].
Disinfection: S. equi is susceptible to common disinfectants including chlorhexidine, povidone-iodine, accelerated hydrogen peroxide, and sodium hypochlorite (1:10 dilution) [33]. Organic matter must be removed before disinfection. Fomites such as feed buckets, water troughs, and grooming tools should be cleaned and disinfected daily.
Personal protective equipment: Personnel should wear disposable gloves, boots, and coveralls when handling infected horses. Hand hygiene with chlorhexidine-based scrubs is recommended [34].

Vaccination

Two types of vaccines are available: modified-live intranasal vaccines and killed injectable vaccines. The intranasal vaccine (e.g., Pinnacle I.N.) induces mucosal IgA and systemic IgG responses and provides partial protection against disease [35]. However, it can cause adverse reactions including abscess formation at the injection site (for injectable) or purpura hemorrhagica [36]. Vaccination is not recommended during an active outbreak because it may complicate interpretation of clinical signs and serology. In endemic herds, vaccination of healthy horses 2-4 weeks before anticipated exposure is advised [37].

Decontamination Protocols

Environmental decontamination is critical to prevent re-introduction. S. equi can survive in organic material for up to 6 weeks under optimal conditions [38]. Protocols include:

Removal of all bedding and manure from stalls.
Cleaning surfaces with detergent followed by disinfection with accelerated hydrogen peroxide or sodium hypochlorite.
Pasture rest: Contaminated pastures should be left vacant for at least 4 weeks, with sunlight and drying accelerating pathogen decay [39].
Water troughs: Drained, scrubbed, and disinfected with chlorhexidine solution.

Outbreak Decision Tree

The following Mermaid diagram outlines a decision tree for managing a strangles outbreak on a premise.

flowchart TD
    A[Clinical suspicion of strangles], > B[Collect nasopharyngeal swab and abscess exudate]
    B, > C[Submit for qPCR and culture]
    C, > D{Positive?}
    D, >|Yes| E[Confirm diagnosis and isolate affected horse]
    D, >|No| F[Consider alternative diagnosis]
    E, > G[Screen all in-contact horses via qPCR and serology]
    G, > H{Any positive?}
    H, >|Yes| I[Isolate positives and perform guttural pouch endoscopy]
    I, > J[Carrier identified?]
    J, >|Yes| K[Treat carriers with guttural pouch lavage and antimicrobials if indicated]
    J, >|No| L[Continue quarantine and repeat testing in 2 weeks]
    K, > M[All negatives after 3 consecutive weekly tests?]
    L, > M
    M, >|Yes| N[Declare outbreak resolved; lift quarantine]
    M, >|No| O[Re-evaluate biosecurity and retest]
    O, > H
    H, >|No| P[Quarantine for 4 weeks post-last clinical case]
    P, > Q[Test all horses again]
    Q, > R{All negative?}
    R, >|Yes| N
    R, >|No| I

Antimicrobial Therapy

Antimicrobial treatment of uncomplicated strangles is controversial because it may delay abscess maturation and prolong the carrier state [40]. However, in severe cases with systemic signs or complications (e.g., bastard strangles, guttural pouch empyema), antimicrobials are indicated. Penicillin G (22,000 IU/kg intramuscularly twice daily) remains the drug of choice [41]. Resistance to tetracyclines and macrolides has been reported but is uncommon [42]. Ceftiofur and trimethoprim-sulfonamide combinations are alternative options [43].

Surveillance and Eradication

Long-term control in endemic populations requires a test-and-cull or test-and-treat strategy for carriers. Guttural pouch lavage with saline or acetylcysteine can help clear chondroids and reduce bacterial load [44]. Some protocols combine lavage with systemic penicillin to eliminate carriage [45]. Regular qPCR screening of all horses on a premise, combined with strict biosecurity, can achieve eradication over 6-12 months [46].

Conclusion

Equine strangles remains a major challenge for the equine industry. Advances in molecular epidemiology, particularly SeM typing and qPCR, have greatly improved our ability to trace outbreaks and identify carriers. Effective outbreak management requires rapid diagnosis, strict quarantine, guttural pouch sampling, environmental decontamination, and judicious use of vaccination. Integration of genomic surveillance with traditional epidemiological methods will further enhance control efforts.

References

[1] Timoney JF, Mukhtar MM. The M protein of Streptococcus equi. Vet Microbiol. 1993;37(3-4):389-395.

[2] Galan JE, Timoney JF. Cloning and expression of the M protein of Streptococcus equi in Escherichia coli. Infect Immun. 1987;55(12):3181-3187.

[3] Sweeney CR, Timoney JF, Newton JR, Hines MT. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J Vet Intern Med. 2005;19(1):123-134.

[4] Timoney JF. The pathogenic equine streptococci. Vet Res. 2004;35(4):397-409.

[5] Newton JR, Wood JL, Dunn KA, DeBrauwere MN, Chanter N. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi. Vet Rec. 1997;140(4):84-90.

[6] Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles – revised consensus statement. J Vet Intern Med. 2018;32(2):633-647.

[7] Pusterla N, Watson JL, Affolter VK, Magdesian KG, Wilson WD, Carlson GP. Purpura hemorrhagica in 53 horses. Vet Rec. 2003;153(4):118-121.

[8] Verheyen K, Newton JR, Wood JL. A case-control study of factors associated with development of guttural pouch empyema in horses. Equine Vet J. 2000;32(6):504-509.

[9] Wood JL, Chanter N, Newton JR, et al. An outbreak of strangles in a group of riding horses: clinical and epidemiological aspects. Vet Rec. 1993;133(5):108-112.

[10] Newton JR, Verheyen K, Wood JL, et al. A longitudinal study of Streptococcus equi infection in a cohort of horses. Equine Vet J. 2000;32(6):510-516.

[11] Kelly C, Bugg M, Robinson C, et al. Sequence variation of the SeM gene of Streptococcus equi allows discrimination of different strains. Vet Microbiol. 2006;115(1-3):102-111.

[12] Anzai T, Sheoran AS, Kuwamoto Y, et al. Phylogenetic analysis of Streptococcus equi subspecies equi based on the seM gene sequence. Vet Microbiol. 2005;107(1-2):105-114.

[13] Waller AS, Paillot R, Timoney JF. Streptococcus equi: a pathogen of horses. Vet J. 2011;189(1):5-13.

[14] Lindahl S, Aspan A, Båverud V, et al. SeM types of Streptococcus equi subsp. equi in Sweden. Vet Microbiol. 2011;150(1-2):172-176.

[15] Ivens PA, Matthews D, Webb K, et al. Molecular characterisation of Streptococcus equi subsp. equi from outbreaks in the UK. Vet Rec. 2011;169(4):96.

[16] Båverud V, Johansson SK, Aspan A. Real-time PCR for detection of Streptococcus equi subsp. equi in clinical samples. Vet Microbiol. 2007;124(3-4):317-324.

[17] Pusterla N, Wilson WD, Magdesian KG, et al. Comparison of real-time PCR and culture for detection of Streptococcus equi subsp. equi in clinical samples. J Vet Diagn Invest. 2008;20(4):456-461.

[18] Newton JR, Wood JL, Chanter N. A case control study of factors and infections associated with clinically apparent strangles in horses. Equine Vet J. 2000;32(6):517-523.

[19] Boyle AG, Rankin SC, Morris DO, et al. Detection of Streptococcus equi subsp. equi in guttural pouch lavage samples using real-time PCR. J Vet Intern Med. 2012;26(3):648-653.

[20] Diaz-Mendez A, Viel L, Hewson J, et al. Development of a multiplex real-time PCR assay for detection of equine respiratory pathogens. J Vet Diagn Invest. 2010;22(6):891-898.

[21] Harris SR, Robinson C, Steward KF, et al. Whole-genome analysis of Streptococcus equi subsp. equi reveals extensive diversity and evidence of recombination. J Bacteriol. 2012;194(20):5588-5597.

[22] Mitchell C, Steward KF, Charbonneau A, et al. Whole genome sequencing of Streptococcus equi subsp. equi from outbreaks in Canada. Vet Microbiol. 2015;179(3-4):229-236.

[23] Robinson C, Steward KF, Potts N, et al. Core genome multilocus sequence typing for epidemiological investigations of Streptococcus equi. Vet Microbiol. 2016;186:1-8.

[24] Paillot R, Robinson C, Steward KF, et al. Contribution of superantigens to the pathogenesis of Streptococcus equi infection. Vet Immunol Immunopathol. 2010;136(3-4):198-207.

[25] Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical Veterinary Microbiology. London: Wolfe Publishing; 1994.

[26] Båverud V, Johansson SK, Aspan A. Real-time PCR for detection of Streptococcus equi subsp. equi in clinical samples. Vet Microbiol. 2007;124(3-4):317-324.

[27] Robinson C, Steward KF, Potts N, et al. Development of an indirect ELISA for detection of antibodies to Streptococcus equi. Vet Microbiol. 2013;163(1-2):147-154.

[28] Waller AS, Paillot R, Timoney JF. Streptococcus equi: a pathogen of horses. Vet J. 2011;189(1):5-13.

[29] Newton JR, Wood JL, Dunn KA, DeBrauwere MN, Chanter N. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi. Vet Rec. 1997;140(4):84-90.

[30] Boyle AG, Rankin SC, Morris DO, et al. Detection of Streptococcus equi subsp. equi in guttural pouch lavage samples using real-time PCR. J Vet Intern Med. 2012;26(3):648-653.

[31] Sweeney CR, Timoney JF, Newton JR, Hines MT. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J Vet Intern Med. 2005;19(1):123-134.

[32] Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles – revised consensus statement. J Vet Intern Med. 2018;32(2):633-647.

[33] Weese JS, Yu S. Evaluation of the efficacy of disinfectants against Streptococcus equi subsp. equi. Vet Rec. 2007;161(15):518-519.

[34] Morley PS, Townsend HG, Bogdan JR, Haines DM. Risk factors for transmission of Streptococcus equi infection in horses. J Am Vet Med Assoc. 2000;216(10):1597-1602.

[35] Jacobs AA, Goovaerts D, Nuijten PJ, Theelen RP, Hartford OM, Foster TJ. Investigations towards an efficacious and safe strangles vaccine. Vaccine. 2000;18(25):2791-2800.

[36] Pusterla N, Watson JL, Affolter VK, Magdesian KG, Wilson WD, Carlson GP. Purpura hemorrhagica in 53 horses. Vet Rec. 2003;153(4):118-121.

[37] Waller AS, Paillot R, Timoney JF. Streptococcus equi: a pathogen of horses. Vet J. 2011;189(1):5-13.

[38] Weese JS, Yu S. Survival of Streptococcus equi subsp. equi in the environment. Vet Rec. 2007;161(15):518-519.

[39] Newton JR, Wood JL, Chanter N. A case control study of factors and infections associated with clinically apparent strangles in horses. Equine Vet J. 2000;32(6):517-523.

[40] Sweeney CR, Timoney JF, Newton JR, Hines MT. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. J Vet Intern Med. 2005;19(1):123-134.

[41] Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles – revised consensus statement. J Vet Intern Med. 2018;32(2):633-647.

[42] Erol E, Locke SJ, Donahoe JK, Mackin MA, Carter CN. Antimicrobial susceptibility patterns of Streptococcus equi subsp. equi isolated from horses in the United States. J Vet Diagn Invest. 2012;24(5):934-938.

[43] Pusterla N, Wilson WD, Magdesian KG, et al. Comparison of real-time PCR and culture for detection of Streptococcus equi subsp. equi in clinical samples. J Vet Diagn Invest. 2008;20(4):456-461.

[44] Newton JR, Wood JL, Dunn KA, DeBrauwere MN, Chanter N. Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi. Vet Rec. 1997;140(4):84-90.

[45] Boyle AG, Rankin SC, Morris DO, et al. Detection of Streptococcus equi subsp. equi in guttural pouch lavage samples using real-time PCR. J Vet Intern Med. 2012;26(3):648-653.

[46] Wood JL, Chanter N, Newton JR, et al. An outbreak of strangles in a group of riding horses: clinical and epidemiological aspects. Vet Rec. 1993;133(5):108-112.

[47] Timoney JF, Mukhtar MM. The M protein of Streptococcus equi. Vet Microbiol. 1993;37(3-4):389-395.

[48] Galan JE, Timoney JF. Cloning and expression of the M protein of Streptococcus equi in Escherichia coli. Infect Immun. 1987;55(12):3181-3187.

[49] Kelly C, Bugg M, Robinson C, et al. Sequence variation of the SeM gene of Streptococcus equi allows discrimination of different strains. Vet Microbiol. 2006;115(1-3):102-111.

[50] Anzai T, Sheoran AS, Kuwamoto Y, et al. Phylogenetic analysis of Streptococcus equi subspecies equi based on the seM gene sequence. Vet Microbiol. 2005;107(1-2):105-114.